These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21135823)

  • 1. Duke's Discovery Genomics center rides pharmacogenomics wave.
    Wapner J
    Nat Med; 2010 Dec; 16(12):1349. PubMed ID: 21135823
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics.
    Hardiman G
    Pharmacogenomics; 2008 Jan; 9(1):5-9. PubMed ID: 18154443
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics: a systems approach.
    Wang L
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(1):3-22. PubMed ID: 20836007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics and pharmacogenetics. 1st Spanish Congress on Pharmacogenomics and Pharmacogenetics, January 23-25, 2005, Valencia, Spain.
    Iqbal O
    Pharmacogenomics; 2005 Apr; 6(3):205-7. PubMed ID: 16013951
    [No Abstract]   [Full Text] [Related]  

  • 5. The relevance of "missing heritability " in pharmacogenomics.
    Sadee W
    Clin Pharmacol Ther; 2012 Oct; 92(4):428-30. PubMed ID: 22910439
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Pharmacogenomics and psychiatric disease.
    Dalton C; Reynolds G
    Neurosci Lett; 2020 May; 726():134602. PubMed ID: 31682873
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics and pharmacogenomics in the discovery and development of medicines.
    Roses AD
    Novartis Found Symp; 2000; 229():63-6; discussion 66-70. PubMed ID: 11084930
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of genomics on anti-infectives drug discovery and development.
    Parkinson T
    Trends Microbiol; 2002; 10(10 Suppl):S22-6. PubMed ID: 12377564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association studies in pharmacogenomics.
    Daly AK
    Nat Rev Genet; 2010 Apr; 11(4):241-6. PubMed ID: 20300088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group.
    Srinivasan BS; Chen J; Cheng C; Conti D; Duan S; Fridley BL; Gu X; Haines JL; Jorgenson E; Kraja A; Lasky-Su J; Li L; Rodin A; Wang D; Province M; Ritchie MD
    Pharmacogenomics; 2009 Feb; 10(2):243-51. PubMed ID: 19207025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network-RIKEN (PGRN-RIKEN) Collaboration.
    Yee SW; Momozawa Y; Kamatani Y; Tyndale RF; Weinshilboum RM; Ratain MJ; Giacomini KM; Kubo M
    Clin Pharmacol Ther; 2016 Nov; 100(5):423-426. PubMed ID: 27256705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics, pharmacogenomics and airway disease.
    Hall IP
    Respir Res; 2002; 3(1):10. PubMed ID: 11806845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK; Takahashi A; Mushiroda T; Kubo M
    Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on the 8th Annual Cold Spring Harbor/Wellcome Trust meeting on Pharmacogenomics and Personalized Medicine.
    Carr DF; Alfirevic A
    Pharmacogenomics; 2011 Mar; 12(3):315-7. PubMed ID: 21449671
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology.
    Kroetz DL; Yee SW; Giacomini KM
    Clin Pharmacol Ther; 2010 Jan; 87(1):109-16. PubMed ID: 19940846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from genome-wide association studies of drug response.
    Zhou K; Pearson ER
    Annu Rev Pharmacol Toxicol; 2013; 53():299-310. PubMed ID: 23072379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coverage rate of ADME genes from commercial sequencing arrays.
    Zaid N; Limami Y; Senhaji N; Errafiy N; Khalki L; Bakri Y; Zaid Y; Amzazi S
    Medicine (Baltimore); 2019 Jan; 98(3):e13975. PubMed ID: 30653102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.